Clinical Trial Update: Combination Treatment for Augmenting Language in Children With ASD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a combination treatment aimed at augmenting language in children with autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: University of California, Los Angeles | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED